Coronavirus Outbreak: USFDA approves albuterol sulfate-based inhaler as demand increases due to COVID-19 pandemic

The generic version of the inhaler will be manufactured by Indian drugmaker Cipla Ltd.

FP Trending April 09, 2020 12:36:21 IST
Coronavirus Outbreak: USFDA approves albuterol sulfate-based inhaler as demand increases due to COVID-19 pandemic

The US Food and Drug Administration (USFDA) has given its nod to the first generic of a commonly used albuterol sulfate-based inhaler.

 <span class=Coronavirus Outbreak USFDA approves albuterol sulfatebased inhaler as demand increases due to COVID19 pandemic" width="380" height="285" class="size-full wp-image-8237661" />

Representational image. Image by HenkieTenk from Pixabay.

The demand for albuterol products has seen a spike as people infected with novel coronavirus suffer from breathing difficulties.

“The FDA recognizes the increased demand for albuterol products during the novel coronavirus pandemic,” said FDA Commissioner Stephen Hahn. He added that they are committed to providing medical products to cater to the needs of the public.

The generic version of the inhaler will be manufactured by Indian drugmaker Cipla Ltd. The albuterol sulfate-based inhaler is used in the treatment of bronchospasm, a condition in which patients face difficulty in breathing.

Last month, the drug regulator had put out a revised draft for proposed generic albuterol sulfate metered dose inhalers.

In its press release, USFDA also highlighted the common side-effects associated with albuterol inhalers.

Click here for coronavirus Outbreak LIVE Updates

Upper respiratory tract infection, rhinitis, nausea, vomiting, rapid heart rate (tachycardia), tremor and nervousness are the most common side-effects, it said.

The novel coronavirus has infected lakhs of people globally and claimed the lives of thousands. It has also brought financial activities across the world to a grinding halt.

The symptoms of coronavirus infection include fever, coughing and breathing difficulties.

Updated Date:

also read

COVID-19 vaccine production increasing, India may be first country to have DNA-based jab, Mansukh Mandaviya tells RS
India

COVID-19 vaccine production increasing, India may be first country to have DNA-based jab, Mansukh Mandaviya tells RS

Replying to a short discussion on COVID-19 management in Rajya Sabha, the minister said technology transfer to several companies has started and they will begin production in the coming days

Centre and states should work as team to combat COVID pandemic, rise above politics, says PM Modi at all-party meet
India

Centre and states should work as team to combat COVID pandemic, rise above politics, says PM Modi at all-party meet

A number of Opposition parties including the Trinamool Congress, NCP and Samajwadi Party attended the meet, while the main Opposition party Congress skipped it

COVID-19: Pakistan bans domestic air travel for unvaccinated as cases cross 1 million mark
World

COVID-19: Pakistan bans domestic air travel for unvaccinated as cases cross 1 million mark

The travel restriction, imposed by the National Command and Operation Centre (NCOC), will be applicable from 1 August on unvaccinated people of over 18 years of age